Literature DB >> 6519127

Autoradiographic and biochemical studies of drug distribution in the liver. III. [14C]Aminotriazole.

T Fujii, H Miyazaki, M Hashimoto.   

Abstract

Whole body autoradiography revealed that the distribution pattern of [14C]aminotriazole in the mouse liver was homogeneous after intravenous administration of the labeled agent and then became heterogeneous (or reticular). Microautoradiography by dry-mounting method revealed that the macroscopic heterogeneous pattern was due to the central localization of the radioactive compound in the hepatic lobule. The present studies indicated that the heterogeneous distribution could be explained as follows. The amount of [14C]aminotriazole circulated to the liver was large since the compound was not so significantly distributed in non-hepatic tissues: distribution pattern was homogeneous in the liver. This was shown by whole body autoradiography and radiometry of tissues. A part of [14C]aminotriazole radioactivity present in the liver was gradually bound covalently to hepatic macromolecules. This was shown by whole body autoradiography after whole body sections of the mouse were extracted by acid, and by the biochemical fractionation of the liver. The covalently bound radioactivity alone became apparent in centrilobular hepatocytes: the distribution was heterogeneous. This was shown by microautoradiography and by the finding that the elimination rate of the bound radioactivity was slower than that of unbound radioactivity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6519127     DOI: 10.1007/BF03189649

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  17 in total

1.  The distribution of labelled aminotriazole in mice.

Authors:  H Tjälve
Journal:  Toxicology       Date:  1975-01       Impact factor: 4.221

2.  Studies on the distribution and fate of S35-labelled benzylpenicillin in the body.

Authors:  S ULLBERG
Journal:  Acta Radiol Suppl       Date:  1954

3.  Autoradiographic techniques for the localization of hormones and drugs at the cellular and subcellular level.

Authors:  W E Stumpf
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1971

4.  The distribution of 35S-chlorpromazine in mice studied by whole body autoradiography.

Authors:  S E Sjöstrand; G B Cassano; E Hansson
Journal:  Arch Int Pharmacodyn Ther       Date:  1965-07

5.  Immunohistochemical localizations of cytochromes P-450 in rat liver.

Authors:  J Baron; J A Redick; F P Guengerich
Journal:  Life Sci       Date:  1978-12-25       Impact factor: 5.037

6.  Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. I. Absorption, distribution, and excrection of [14C]tolmetin radioactivity.

Authors:  M Hashimoto; H Miyazaki; T Fujii; K Nambu; K Tanaka
Journal:  Drug Metab Dispos       Date:  1979 Jan-Feb       Impact factor: 3.922

7.  Phenobarbital-induced fine structural changes in rat liver.

Authors:  P C Burger; P B Herdson
Journal:  Am J Pathol       Date:  1966-05       Impact factor: 4.307

8.  The distribution of 14c from [U-14c]glucose in mice using whole-body autoradiography.

Authors:  M Shimada; T Kihara; M Watanabe; K Kurimoto
Journal:  J Histochem Cytochem       Date:  1976-04       Impact factor: 2.479

9.  [Disposition and metabolism of 14C-dehydrocorydaline in mice and rats].

Authors:  T Fujii; H Miyazaki; K Nambu; A Kagemoto; M Hashimoto
Journal:  Radioisotopes       Date:  1984-08

10.  Autoradiographic and biochemical studies of drug distribution in the liver. II. [35S]Chlorpromazine and [14C]imipramine.

Authors:  T Fujii; H Miyazaki; K Nambu; K Matsumoto; M Hashimoto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jul-Sep       Impact factor: 2.441

View more
  1 in total

1.  Autoradiographic and biochemical studies of drug distribution in the liver. I. [14C]Dehydrocorydaline.

Authors:  T Fujii; H Miyazaki; K Nambu; H Furukawa; M Hashimoto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jul-Sep       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.